Preclinical photodynamic therapy in Spain 2: Liposome vectorization of photosensitizers. Different strategies, different outcomes

Journal of Porphyrins and Phthalocyanines

Volumn 13, Issue 4-5, 2009, Pages 537-543

  Mora, Margarita ^a   Sagristá, M Lluïsa ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Controlled release; Liposomes; Photodynamic therapy; Photosensitizers; Targeted drug delivery

Indexed keywords

EID: 68349146285     PISSN: 10884246     EISSN: None     Source Type: Journal    
DOI: 10.1142/s108842460900053x     Document Type: Article

References (80)

1. Hopper C. Lancet Oncol. 2000; 1: 212-219.
2. Dolmans DEJGJ, Fukumura D and Jain RK. Nat. Rev., Cancer. 2003; 3: 380-387.
3. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q. J. Natl. Cancer Inst. 1998; 90: 889-905.
4. Ceburkov O and Golinick H. Eur. J. Dermatol. 2000; 10: 568-576.
5. Kalka K, Merk H and Mukhtar H. J. Am. Acad. Dermatol. 2000; 42: 389-413.
6. Dougherty TJ. J. Clin. Laser Med. Surg. 2002; 20: 3-7.
7. Kormeili T, Yamauchi PS and Lowe NJ. Br. J. Dermatol. 2004; 150: 1061-1069.
8. Ben-Hur E, Geacintov NE, Studamire B, Kenney ME and Horowitz B. Photochem. Photobiol. 1995; 61: 190-195.
9. Malik Z, Hanania J and Nitzan Y. J. Photochem. Photobiol., B 1990; 5: 281-293.
10. Brockhorst K, Els T and Hoelin-Berlage M. J. Magn. Reson. Imaging. 1994; 4: 451-456.
11. Niesman MR, Khoobehi B, Magin RL and Webb AG. J. Lipos. Res. 1994; 4: 741-768.
12. Bonnett R. Chemical Aspects of Photodynamic Therapy, Gordon and Breach Science Publishers: Amsterdam, 2000; pp 115-128.
13. Rubio N, Prat F, Bou N, Borrell JI, Teixidó J, Villanueva A, Juarranz A, Cañete M, Stockert JC and Novell S. New J. Chem. 2005; 2: 378-384.
14. Brault D, Aveline B, Delgado O and Martin MT. Photochem. Photobiol. 2001; 73: 331-338.
15. Das K, Jain B, Dube A and Gupta PK. Chem. Phys. Lett. 2005; 401: 185-188.
16. Rancan F, Wiehe A, Nöbel M, Senge MO, Al Omari S, Böhm F, John M and Röder B. J. Photochem. Photobiol., B 2005; 78: 17-28.
17. Nyman ES and Hynninen PH. J. Photochem. Photobiol., B 2004; 73: 1-28.
18. Wohrle D, Hirth A, Bogdahn-Rai T, Schnurofeil G and Shopova M. Russ. Chem. Bull. 1998; 47: 807-816.
19. Derycke ASL and De Witte PAM. Int. J. Oncol. 2002; 20: 181-187.
20. Zhang G, Harada A, Nishiyama N, Jiang D, Koyama H, Aida T and Kataoka K. J. Controlled Release 2003; 93: 141-150.
21. Torchilin V. Eur. J. Pharm. Sci. 2000; 11, suppl. 2: S81-S91.
22. Sharman WM, van Lier JE and Allen CM. Adv. Drug Deliv. Rev. 2004; 56: 53-76.
23. Lasic DD and Papahadjopoulos D. Science. 1995; 267: 1275-1276.
24. Gabizon A. In Medical Applications of Liposomes, Lasic DD and Papahadjopoulos D. (Eds.), Elsevier Science: New York, 1998; pp 625-634.
25. Lasic DD. Trends Biotechnol. 1998; 16: 307-327.
26. Gregoriadis G. J. Drug Target. 1993; 1: 3-6.
27. Barenholz Y. Curr. Opin. Colloid Interface Sci. 2001; 6: 66-77.
28. Betageri GV, Jenkins SA and Parsons DL. Liposome drug delivery systems. Technomic Publishing Company, Inc.: Lancaster, 1993.
29. Storm G and Woodle MC. In Long Circulating Liposomes, Woodle MC and Storm G. (Eds.), Springer-Verlag: Berlin, 1998; pp 3-16.
30. Nässander UK, Storm G, Peeters PAM and Crom-melin DJA. In Biodegradable Polymers as Drug Delivery Systems, Chasin M and Langer R. (Eds.), Marcel Dekker: New York, 1990; pp 261-238.
31. Keam SJ, Scott LJ and Curran MP. Drugs 2003; 63: 2521-2554.
32. Forssen E. Adv. Drug Deliv. Rev. 1997; 24: 133-150.
33. Batist G, Harris L, Azarnia N, Lee LW and Daza-Ramirez P. Anticancer Drugs 2006; 17: 587-595.
34. Boswell GW, Buell D and Bekersky I. J. Clin. Pharmacol. 1998; 38: 583-592.
35. Pinto-Alphandary H, Andremont A and Couvreur P. Int. J. Antimicrob. Agents 2000; 13: 155-168.
36. Justo OR and Moraes AM. Drug Deliv. 2003; 10: 201-207.
37. Maesaki S. Curr. Pharm. Des. 2002; 8: 433-440.
38. Lanao JM, Briones E and Colino CI. J. Drug Targeting 2007; 15: 21-36.
39. Khatri K, Goyal AK, Gupta PN, Mishra N, Mehta A and Vyas SP. Vaccine 2008; 26: 2225-2233.
40. Beauchesne PR, Chung NS and Wasan KM. Drug Dev. Ind. Pharm. 2007; 33: 211-220.
41. Barratt G. Cell Mol Life Sci. 2003; 60: 21-37.
42. Samad A, Sultana Y and Aquil M. Curr. Drug Deliv. 2007; 4: 297-305.
43. Senior J. CRC Crit. Reviews Therapeut. Drug Carrier Systems 1987; 37: 123-193.
44. Sapra P and Allen TM. Prog. Lipid Res. 2003; 42: 439-462.
45. Koning GA, Morselt HWM, Gorter A, Allen TM, Zalipsky S, Scherphof GL and Kamps JA. Pharm. Res. 2003; 20: 1249-1257.
46. Gosselin MA and Lee RJ. Biotechnol. Annu. Rev. 2002; 8: 103-131.
47. Zhao X, Li H and Lee RJ. Expert Opin. Drug Deliv. 2008; 5: 309-319.
48. Lasic DD and Papahadjopoulos D. Medical Applications of Liposomes, Elsevier Science BV: Amsterdam, 1998.
49. Allen TM, Brandeis E, Hansen CB, Kao GY, Kalip-sky S and Gabizon A. Biochim. Biophys. Acta. 1995; 1237: 99-108.
50. Zelphati O and Szoka FC. J. Controlled Release 1996; 41: 99-119.
51. Park JW, Benz CC and Martin FJ. Semin. Oncol. 2004; 31: 196-205.
52. Mora M, Sagristá ML, Trombetta D, Bonina FP, De Pasquale A and Saija A. Pharm. Res. 2002; 19: 1430-1438.
53. Hong MS, Lim SJ, Oh YK and Kim CK. J. Pharm. Pharmacol. 2002; 54: 51-58.
54. Karanth H and Murthy RS. J. Pharm. Pharmacol. 2007; 59: 469-483.
55. Huang A, Kennel SJ and Huang LJ. J. Biol. Chem. 1983; 258: 14034-14040.
56. Yatvin MB, Weinstein JN, Dennis WH and Blumen-thal R. Science 1978; 202: 1290-1293.
57. Weinstein JN, Magin RL, Cysyk RL and Zaharko DS. Cancer Res. 1980; 40: 1388-1395.
58. Needham D and Dewhirst MW. Adv. Drug Deliv. Rev. 2001; 53: 285-305.
59. Arancia G, Calcabrini A, Matarrese P, Marcocci I, Pietrangeli P and Mondovi B. Int. J. Hyperthermia. 1994; 10: 101-114.
60. Kong G and Dewhirst MW. Int. J. Hyperthermia. 1999; 15: 345-370.
61. Illum L, Jacobsen LO, Müller RH, Mak E and Davis SS. Biomaterials 1987; 8: 113-117.
62. Woodle MC and Lasic DD. Biochim. Biophys. Acta. 1992; 1113: 171-199.
63. Allen TM and Papahadjopoulos D. In Liposome Technology (2nd edn), Vol. 3, Gregoriadis G. (Ed.), CRC Press: Boca Raton, 1992; pp 59-72.
64. Immordino ML, Dosio F and Cattel L. Int. J. Nanomedicine. 2006; 1: 297-315.
65. Jones MN. Adv. Colloid Interface Sci. 1995; 54: 93-128.
66. Sagristá ML, Mora M and De Madariaga MA. Cel. Mol. Biol. Lett. 2000; 5: 19-33.
67. Kono K, Iwamoto M, Nishikawa R, Yanagie H and Takagishi T. J. Controlled Release 2000; 68: 225-235.
68. Ortiz J, Rosell F, Mora M and De Madariaga MA. Chem. Phys. Lipids 1992; 61: 185-191.
69. Atif SM, Hasan I, Ahmad N, Khan U and Owais M. FEBS Lett. 2006; 580: 2183-2190.
70. Goto T, Morishita M, Nishimura K, Nakanishi M, Kato A, Ehara J and Takayama K. Pharm. Res. 2006; 23: 384-391.
71. Puyal C, Maurin L, Miruel G, Bienvenüe A and Philippot J. Biochim. Biophys. Acta. 1994; 1195: 259-266.
72. Mora M, Mir F, De Madariaga MA and Sagristá ML. Lipids 2000; 35: 513-524.
73. Domingo JC, Mora M and De Madariaga MA. Biochim. Biophys. Acta 1993; 1148: 308-316.
74. Mercadal M, Domingo JC, Bermúdez M, Mora M and De Madariaga MA. Biochim. Biophys. Acta 1995; 1235: 281-288.
75. Sagristá ML, Bermúdez M, De Madariaga MA and Mora M. Recent Res. Devel. Lipid Res. 1999; 3: 127-158.
76. Hoebeke M. J. Photochem. Photobiol., B 1995; 28: 189-196.
77. Derycke ASL and Witte PAM. Adv. Drug Deliv. Rev. 2004; 56: 17-30.
78. Postigo F, Mora M, De Madariaga MA, Nonell S and Sagristá ML. Int. J. Pharm. 2004; 278: 239-254.
79. Ricchelli F. J. Photochem. Photobiol., B 1995; 29: 109-118.
80. Postigo F, Sagristá ML, De Madariaga MA, Nonell S and Mora M. Biochim. Biophys. Acta 2006; 1758: 583-596.